Though not shown on the heatmap, podoplanin was similarly significantly up-regulated in AML patients with low expression of siglec9 (FC = − 4.04, p.adj = 1.18 × 10–9). The gene discussed is SIGLEC9; the disease is acute myeloid leukemia.